Catching up on the FDA compounding news from this week. For anyone who missed it — the agency clarified requirements that affect how compounders handle GLP-1 medications while the branded versions stay in shortage or come off it. Practically, this could change what's available from telehealth providers and at what price. Has this already affected anyone's orders? Curious how the community is reading the guidance.
Compounding pharmacies and the new FDA guidance — discussion
Following because I'm in the same boat. Week 11, 2.5mg, and the plateau is real. I'm trying to be patient but it's frustrating.
Login to reply to this thread.
Login / Sign up